> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Biosimilar User Fees
- URL: https://www.fdaweb.com/info-collection-on-biosimilar-user-fees/
- Published: 2021-09-16T12:00:00.000Z
- Updated: 2026-09-14T17:14:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150156

*Federal Register* notice: FDA is seeking comments on an information collection revision entitled “Biosimilars User Fee Program” (OMB Control Number 0910-0718). For efficiency purposes, the agency is consolidating a related information collection on current user fee commitment goals as set forth in the document “BsUFA Reauthorization Performance Goals and Procedures Fiscal Years 2018 Through 2022.” To view the notice, click [here](https://public-inspection.federalregister.gov/2021-20060.pdf?ref=fdaweb.com).